Publications by authors named "Xu Xiaoding"

Claim this Profile
C
Corrigendum to "Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy" [Acta Biomaterialia 162 (2023) 98-109].
Linzhuo Huang, Rui Xu, Weirong Li, Li Lv, Chunhao Lin, Xiaoding Xu

Acta Biomater· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-Delivery of Chemotherapy and Anti-Angiogenic Lipid via DPPA-LNPs Potentiates Anti-PD-1 Immunotherapy.
Jiabao Tan, Junyue Fang, Wanrong Luo, Xiaojiang Chen, Yixia Liang, Xiaoding Xu

Int J Nanomedicine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mA-Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism.
Juanyi Shi, Sintim Mui, Yongcong Yan, Shaomin Liu, Kai Wen, Xiaoding Xu

Adv Sci (Weinh)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticle-induced excessive mitophagy combined with immune checkpoint blockade for enhanced cancer immunotherapy.
Yuan Cao, Rui Xu, Junyue Fang, Zixuan Zhao, Guo Wu, Xiaoding Xu

Acta Biomater· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction-responsive RNAi nanoplatform for enhanced cancer sonoimmunotherapy via dual inhibition of mitophagy and Nrf2 pathways.
Junyue Fang, Rui Xu, Yuan Cao, Zixuan Zhao, Weifan Li, Xiaoding Xu

Theranostics· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy With Cisplatin Up-Regulates GSDMD to Enhance Oral Squamous Cell Carcinoma Metastasis Through MMP14-Mediated EMT Activation.
Zixian Huang, Qiming Jiang, Qianyu Zhang, Nan Lu, Xi Rui, Xiaoding Xu

Adv Sci (Weinh)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of recurrence and metastasis in triple-negative breast cancer through nanoparticle-mediated silencing of LPCAT1 to remodel ATP energy metabolism.
Xiuling Li, Senlin Li, Haotian Li, Guo Wu, Huijie Zhao, Xiaoding Xu

Sci China Life Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-Responsive Immunomodulatory RNAi Nanoplatform for Effective Immune Checkpoint Blockade and Enhanced Cancer Immunotherapy.
Yuan Cao, Zixuan Zhao, Junyue Fang, Yanan Lu, Zhuoshan Huang, Xiaoding Xu

Adv Healthc Mater· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticles (NPs)-mediated silencing of GSTP1 expression to reverse chemoresistance for effective breast cancer therapy.
Qian Shen, Ke Yang, Qingjian Li, Tao Qin, Yunfang Yu, Xiaoding Xu

J Colloid Interface Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreas-targeted lipid nanoparticles for relatively non-invasive interleukin-12 mRNA therapy in orthotopic pancreatic ductal adenocarcinoma.
Qian Shen, Jia Liu, Ling Zeng, Yupeng Ren, Jing Liao, Xiaoding Xu

J Control Release· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCL1A in naïve B cells as a therapeutic target for type 1 diabetes.
Siweier Luo, Lina Zhang, Chunfang Wei, Chipeng Guo, Zhe Meng, Xiaoding Xu

EBioMedicine· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulating lipid metabolism by nanoparticles (NPs)-mediated ACSL3 silencing to inhibit hepatocellular carcinoma growth and metastasis.
Linzhuo Huang, Rui Xu, Siyu Chen, Chunhao Lin, Wende Li, Xiaoding Xu

Mol Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticle-mediated efficient up-regulation of GSDMD-N to induce pyroptosis and enhance NK cell-based cancer immunotherapy.
Zixian Huang, Chunfang Wei, Chen Yi, Qiming Jiang, Yong-Qiang Wang, Xiaoding Xu

Acta Biomater· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mechanistical principles and engineering application of roof- cutting for roadway protection in advance of the working face.
Zhaotai Li, Yuejin Zhou, Xiaoding Xu, Yuhang Xiao, Yunong Xu

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA Damage-Sensitized metal phenolic nanosynergists potentiate Low-Power phototherapy for osteosarcoma therapy.
Chunxue Song, Fei Wu, Shucong Yao, Haimin Chen, Ronglong Chen, Xiaoding Xu

J Colloid Interface Sci· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LncRNA FAISL Inhibits Calpain 2-Mediated Proteolysis of FAK to Promote Progression and Metastasis of Triple Negative Breast Cancer.
Yunmei Zhang, Shiyu Wei, Zhengjie Chen, Rui Xu, Shu-Rong Li, Xiaoding Xu

Adv Sci (Weinh)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioactive Nanotherapeutic Ultrasound Contrast Agent for Concurrent Breast Cancer Ultrasound Imaging and Treatment.
Junyue Fang, Jiabao Tan, Li Lin, Yuan Cao, Rui Xu, Xiaoding Xu

Adv Healthc Mater· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in targeted delivery of mRNA into immune cells for enhanced cancer therapy.
Linzhuo Huang, Zhiquan Huang, Yuxuan Zhang, Chunhao Lin, Zixuan Zhao, Xiaoding Xu

Theranostics· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LncOCMRL1 promotes oral squamous cell carcinoma growth and metastasis via the RRM2/EMT pathway.
Nan Lu, Qiming Jiang, Tianshu Xu, Qiyuan Gao, Yuepeng Wang, Xiaoding Xu

J Exp Clin Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excessive fatty acids activate PRMT5/MDM2/Drosha pathway to regulate miRNA biogenesis and lipid metabolism.
Aijun Hou, Xiaoding Xu, Yu Zhang, Hongxiu He, Yihan Feng

Liver Int· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-Decorated Nanoplatform to Reprogram Macrophage and Block Immune Checkpoint LSECtin for Effective Cancer Immunotherapy.
Rui Xu, Xiangya Liu, Yuxuan Zhang, Guo Wu, Linzhuo Huang, Xiaoding Xu

Nano Lett· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular vesicle surface display of αPD-L1 and αCD3 antibodies via engineered late domain-based scaffold to activate T-cell anti-tumor immunity.
Rui Chen, Ziqin Kang, Wenhao Li, Tianshu Xu, Yongqiang Wang, Xiaoding Xu

J Extracell Vesicles· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticles (NPs)-mediated lncMALAT1 silencing to reverse cisplatin resistance for effective hepatocellular carcinoma therapy.
Ting Wang, Qianyao Li, Rui Xu, Zixuan Zhao, Qi Sun, Xiaoding Xu

Front Pharmacol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research on the ratio of similar materials in water-absorbent mudstone based on fuzzy mathematics.
Chunlin Zeng, Yuejin Zhou, Xu Xiaoding

Sci Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy.
Xiaodi Liu, Qi Zhang, Yixia Liang, Shiyu Xiong, Yan Cai, Xiaoding Xu

Acta Pharm Sin B· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis